MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Novavax Inc

Geschlossen

BrancheGesundheitswesen

5.61 -6.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.35

Max

5.97

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

-81M

Verkäufe

3.8M

88M

EPS

-0.52

Gewinnspanne

-91.755

Angestellte

952

EBITDA

52M

-53M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+146.66% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

9. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-140M

1.1B

Vorheriger Eröffnungskurs

12.42

Vorheriger Schlusskurs

5.61

Nachrichtenstimmung

By Acuity

75%

25%

361 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Novavax Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Apr. 2025, 17:06 UTC

Wichtige Markttreiber

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31. März 2025, 14:19 UTC

Wichtige Markttreiber

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4. Feb. 2025, 18:52 UTC

Wichtige Markttreiber

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11. Nov. 2024, 14:05 UTC

Wichtige Markttreiber

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16. Okt. 2024, 12:59 UTC

Wichtige Markttreiber

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

13. Mai 2024, 18:14 UTC

Wichtige Markttreiber

Novavax Shares Pop Another 50% Following Sanofi Deal

10. Mai 2024, 10:59 UTC

Wichtige Markttreiber

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

30. Dez. 2024, 23:02 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4. Dez. 2024, 07:09 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax: Agreement to Close by Dec 30 >NVAX

4. Dez. 2024, 07:08 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4. Dez. 2024, 07:07 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4. Dez. 2024, 07:06 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4. Dez. 2024, 07:06 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4. Dez. 2024, 07:04 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15. Nov. 2024, 13:34 UTC

Top News

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15. Nov. 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16. Okt. 2024, 15:22 UTC

Ergebnisse

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

10. Mai 2024, 20:11 UTC

Ergebnisse

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10. Mai 2024, 14:49 UTC

Ergebnisse
Heiße Aktien

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

10. Mai 2024, 10:47 UTC

Akquisitionen, Fusionen, Übernahmen

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Peer-Vergleich

Kursveränderung

Novavax Inc Prognose

Kursziel

By TipRanks

146.66% Vorteil

12-Monats-Prognose

Durchschnitt 14.75 USD  146.66%

Hoch 19 USD

Tief 9 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Novavax Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

2

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

N/A / 7.011Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

361 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.